Robert Lorne Hopfner, Director, 10% Owner at Inozyme Pharma, Inc. (INZY), bought 1,591,154 shares at $16.00 ($3.0M) on 2020-07-28, disclosed to the SEC on 2020-07-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,403,654 | $0 | 0.0% |
| 2 | $16.00 | 187,500 | $3.0M | 100.0% |
| Total | $1.89 avg | 1,591,154 | $3.0M | 100% |
| Filing → |
| INZY | BUY | 2023-05-15 | $5.7M | — | Filing → |
| INZY | BUY | 2023-03-30 | $3.1M | — | Filing → |
| INZY | BUY | 2023-03-29 | $1.7M | — | Filing → |